Literature DB >> 27321036

PET-Based Percutaneous Needle Biopsy.

Ghassan El-Haddad1.   

Abstract

PET can be used to guide percutaneous needle biopsy to the most metabolic lesion, improving diagnostic yield. PET biopsy guidance can be performed using visual or software coregistration, electromagnetic needle tracking, cone-beam computed tomography (CT), and intraprocedural PET/CT guidance. PET/CT-guided biopsies allow the sampling of lesions that may not be clearly visible on anatomic imaging, or of lesions that are morphologically normal. PET can identify suspicious locations within complex tumors that are most likely to contain important diagnostic and prognostic information.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FDG; Fusion; Image guidance; Navigation; PET/CT; Percutaneous biopsy; Tissue sampling

Mesh:

Year:  2016        PMID: 27321036     DOI: 10.1016/j.cpet.2016.02.009

Source DB:  PubMed          Journal:  PET Clin        ISSN: 1556-8598


  3 in total

1.  Comparison Between CBCT and Fusion PET/CT-CBCT Guidance for Lung Biopsies.

Authors:  Federico Fontana; Filippo Piacentino; Anna Maria Ierardi; Gianpaolo Carrafiello; Andrea Coppola; Alessandra Muollo; Alessandro Beneventi; Chiara Floridi; Andrea Selenito Imperatori; Giulio Carcano; Massimo Venturini
Journal:  Cardiovasc Intervent Radiol       Date:  2020-09-07       Impact factor: 2.740

2.  Comparison of CT and PET/CT for biopsy guidance in oncological patients.

Authors:  Juliano J Cerci; Elena Tabacchi; Mateos Bogoni; Dominique Delbeke; Carlos Cunha Pereira; Rodrigo J Cerci; Cassiano Krauzer; Danielle Giacometti Sakamoto; Stefano Fanti; João Vicente Vitola
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-31       Impact factor: 9.236

Review 3.  Application of Multimodality Imaging Fusion Technology in Diagnosis and Treatment of Malignant Tumors under the Precision Medicine Plan.

Authors:  Shun-Yi Wang; Xian-Xia Chen; Yi Li; Yu-Ying Zhang
Journal:  Chin Med J (Engl)       Date:  2016-12-20       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.